Pancreatic Cancer - Pipeline Review, 2015 - New Report Available

From: Fast Market Research, Inc.
Published: Wed Nov 04 2015

GlobalData's Medical Devices sector report, "Pancreatic Cancer - Pipeline Review, 2015" provides an overview of Pancreatic Cancer diagnostic tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Pancreatic Cancer diagnostic tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Report Scope

* Extensive coverage of the Pancreatic Cancer diagnostic tests under development
* The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
* The report reviews the major players involved in the development of Pancreatic Cancer diagnostic tests and list all their pipeline projects
* The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
* The report provides key clinical trial data of ongoing trials specific to pipeline products
* Recent developments in the segment / industry

Full Report Details at

Reasons to Get this Report

The report enables you to -

* Formulate significant competitor information, analysis, and insights to improve R&D strategies
* Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
* Identify and understand important and diverse types of Pancreatic Cancer diagnostic tests under development
* Develop market-entry and market expansion strategies
* Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
* In-depth analysis of the product's current stage of development, territory and estimated launch date

Companies Mentioned in this Report: A&G Pharmaceutical, Inc., Abcodia Ltd., Acobiom, Andraka Technologies, LLC, Applied Proteomics, Inc., Asuragen, Inc., BioMarker Strategies, LLC, Biouniversa s.r.l., Cancer Research Technology Limited, Cellmid Limited, Cepheid, Chronix Biomedical, Inc., Cleveland Diagnostics Inc., Clovis Oncology, Inc., CompanDX Ltd., Courtagen Life Sciences, Inc., CS-Keys, Inc., Dartmouth College, Di.V.A.L Toscana srl, Exact Sciences Corporation, GeneFluidics Inc., German Cancer Research Center, GlycoZym, Health Discovery Corporation, Hebrew University of Jerusalem, ImmunoCellular Therapeutics, Ltd., Immunomedics, Inc., Imperial College London, IV Diagnostics, Inc., Matrix-Bio, Inc., Mayo Clinic, MDNA Life Sciences, Inc., Merrimack Pharmaceuticals, Inc., Metanomics Health GmbH, Milagen, Inc., Miraculins Inc., NanoScale Corporation, NatiMab Therapeutics S.r.l., National Cheng-Kung University Hospital, Neogenix Oncology, Inc., Onconome, Inc., OPKO Health, Inc., Oxford Gene Technology Limited, PeriRx LLC, Precision Biologics, Inc., Proplex Technologies, Llc, Protagen AG, SDIX, LLC, Sienna Cancer Diagnostics Ltd, SomaLogic, Inc., Source MDx, Stanford University, The Johns Hopkins University, Thomas Jefferson University, US Biomarkers, Inc., Viomics Inc., Vitatex Inc., VolitionRX Ltd.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Ovarian Cancer - Pipeline Review, 2015
- Liver Cancer - Pipeline Review, 2015
- Pancreatic Cancer - Pipeline Review, H1 2015
- Metastatic Pancreatic Cancer - Pipeline Review, H1 2015
- Bladder Cancer - Pipeline Review, H2 2015

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »